Tarja Linnankivi Selected Research

Kv1.2 Potassium Channel

4/2015

De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tarja Linnankivi Research Topics

Disease

2	Muscle Spasticity (Spastic) 01/2016 - 07/2015
2	Epileptic Syndromes 01/2016 - 11/2013
2	Brain Diseases (Brain Disorder) 07/2015 - 04/2015
2	Cerebroretinal Microangiopathy with Calcifications and Cysts 03/2012 - 06/2011
2	Leukoencephalopathies 03/2012 - 06/2011
2	Cysts 03/2012 - 06/2011
1	Ataxia (Dyssynergia) 12/2023
1	Infantile Spasms (West Syndrome) 01/2022
1	Dystonia (Limb Dystonia) 01/2020
1	Dementia (Dementias) 01/2020
1	Parkinsonian Disorders (Parkinsonism) 01/2020
1	Epilepsy (Aura) 01/2020
1	Pulmonary Hypertension 01/2016
1	Paresis (Hemiparesis) 01/2016
1	Alkalosis 01/2016
1	Renal Insufficiency (Renal Failure) 01/2016
1	Hyperuricemia 01/2016
1	Atrophy 07/2015
1	Quadriplegia (Spastic Quadriplegia) 07/2015
1	Seizures (Absence Seizure) 11/2013
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 11/2013
1	Cognitive Dysfunction 11/2013
1	Fever (Fevers) 11/2013
1	Revesz Debuse syndrome 03/2012

Drug/Important Bio-Agent (IBA)

2	Retinaldehyde (Retinal)IBA 03/2012 - 06/2011
1	Nonsense Codon (Nonsense Mutation)IBA 12/2023
1	Vigabatrin FDA Link 01/2022
1	IronIBA 01/2020
1	Serine-tRNA LigaseIBA 01/2016
1	EnzymesIBA 01/2016
1	selenocysteinyl-tRNAIBA 07/2015
1	Transfer RNA (tRNA)IBA 07/2015
1	SelenocysteineIBA 07/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 07/2015
1	Selenoproteins (Selenoprotein)IBA 07/2015
1	Kv1.2 Potassium ChannelIBA 04/2015
1	Shelterin ComplexIBA 03/2012

Therapy/Procedure

1	Therapeutics 11/2013